Unlock instant, AI-driven research and patent intelligence for your innovation.

Duck reovirus, duck tembusu virus and duck adenovirus triple inactivated vaccine and preparation method thereof

A technology of duck Tembusu virus and reovirus, applied in biochemical equipment and methods, vaccines, viruses, etc., can solve problems such as mutual interference and reduced immune effect, achieve stable quality, simple preparation method, and strengthen duck The effect of the body's immune function

Pending Publication Date: 2020-04-14
广州渔跃生物技术有限公司
View PDF9 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] Group I type 2 adenovirus disease is mainly a type of disease caused by duck adenovirus. The main clinical symptoms are pericardial effusion and liver necrosis. Only the development of vaccines is the key to preventing these three viruses, but a variety of antigens are made into vaccines. It is easy to cause mutual interference, and multiple antigens compete with each other, reducing the immune effect, so there is still room for improvement

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Duck reovirus, duck tembusu virus and duck adenovirus triple inactivated vaccine and preparation method thereof
  • Duck reovirus, duck tembusu virus and duck adenovirus triple inactivated vaccine and preparation method thereof
  • Duck reovirus, duck tembusu virus and duck adenovirus triple inactivated vaccine and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0051] S1. Preparation of cell carrier: After digestion and dispersion of LMH cells with 0.25% trypsin, DMEM / F12 medium with 5% newborn calf serum added to the cell monolayer at 37°C and 5% CO2 in a spinner flask , Discard the DMEM / F12 culture medium of 5% newborn calf serum, inoculate the cell maintenance medium, wash the cells with serum-free DMEM / F12 culture medium 3 times to obtain the cell carrier;

[0052] The cell maintenance fluid contains serum-free DMEM / F12 culture fluid, 2mM / ML glutamine, 0.2mM / ML N-N-diethyl-1-4-phenylenediamine;

[0053] S2. Virus inoculation: inoculate the viral liquids of duck reovirus, duck tambusu virus and duck adenovirus in a volume of 4:4:2 into the cell vector obtained in step S1, and place it at 37°C for adsorption Aspirate and discard the virus solution after 30 minutes, and then add DMEM / F12 culture solution containing 1% newborn calf serum and culture for 48 hours at 37°C and 5% CO2. Harvest the diseased cells when the cytopathic effect rea...

Embodiment 2

[0063] S1. Preparation of cell carrier: After digesting and dispersing LMH cells with 0.25% trypsin, adding 7% newborn calf serum to the DMEM / F12 culture solution in a spinner flask at 37°C and 5% CO2, after it is cultured to the cell monolayer , Discard the DMEM / F12 culture medium of 7% newborn calf serum, inoculate the cell maintenance medium, and wash the cells with serum-free DMEM / F12 culture medium for 3 times to obtain the cell carrier;

[0064] The cell maintenance fluid contains serum-free DMEM / F12 culture fluid, 2mM / ML glutamine, 0.2mM / ML N-N-diethyl-1-4-phenylenediamine;

[0065] S2. Virus inoculation: inoculate the viral liquids of duck reovirus, duck tambusu virus and duck adenovirus in a volume of 4:4:2 into the cell vector obtained in step S1, and place it at 37°C for adsorption Aspirate and discard the virus solution after 35 minutes, then add 1.5% newborn calf serum-containing DMEM / F12 culture solution and culture for 48 hours at 37°C and 5% CO2. When the cytopathic...

Embodiment 3

[0075] S1. Preparation of cell carrier: After digesting and dispersing LMH cells with 0.25% trypsin, adding 9% newborn calf serum in DMEM / F12 culture solution in a spinner flask at 37°C and 5% CO2, after culturing to the cell monolayer , Discard the DMEM / F12 culture medium with 9% newborn calf serum, inoculate the cell maintenance medium, wash the cells 3 times with serum-free DMEM / F12 medium to obtain the cell carrier;

[0076] The cell maintenance fluid contains serum-free DMEM / F12 culture fluid, 2mM / ML glutamine, 0.2mM / ML N-N-diethyl-1-4-phenylenediamine;

[0077] S2. Virus inoculation: inoculate the viral liquids of duck reovirus, duck tambusu virus and duck adenovirus in a volume of 4:4:2 into the cell vector obtained in step S1, and place it at 37°C for adsorption After 40 minutes, aspirate and discard the virus solution, then add DMEM / F12 culture solution containing 2% newborn calf serum and culture for 48 hours at 37°C and 5% CO2. When the cytopathic effect reaches 80%, har...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to the field of inactivated vaccines. The problem that the immune effect of ducks is poor is solved. The invention provides a duck reovirus, duck tembusu virus and duck adenovirus triple inactivated vaccine and a preparation method thereof. According to the technical scheme, the vaccine consists of a duck reovirus antigen, a duck tembusu virus antigen, a duck adenovirus antigen and an adjuvant containing casein with the concentration of 8mmol / L to 11mmol / L; the content of the duck reovirus antigen is 10<8.0> TCID50 / mL to 10<8.5> TCID50 / mL; the content of the duck tembusuvirus antigen is 10<8.0> TCID50 / mL to 10<8.5> TCID50 / mL; and the content of the duck adenovirus antigen is 10<8.0> TCID50 / mL to 10<8.5> TCID50 / mL. The triple inactivated vaccine for the duck reovirus,the duck tembusu virus and the duck adenovirus is provided, so that the duck reovirus antigen, the duck tembusu virus antigen and the duck adenovirus antigen do not interfere with one another, and the immune function of a duck body is enhanced.

Description

Technical field [0001] The invention relates to the field of multiple inactivated vaccines, in particular to a triple inactivated vaccine of duck reovirus, duck tempusu virus and duck adenovirus and a preparation method thereof. Background technique [0002] Muscovy duck reovirus disease is an acute and severe infectious disease caused by duck reovirus (MDRV). The disease is caused by the appearance of white necrotic spots in the liver and spleen and other organs. It is also known as Muscovy Duck Liver White Spot Disease or Flower Liver Disease. It has a high morbidity and fatality rate. The disease mostly occurs between 7-35 days of age and 10-25 Day-old Muscovy ducklings are most likely to occur, with an incidence rate of 30%-90% and a mortality rate of 60%-80%. Duck reovirus (MDRV) is spherical in shape, has no envelope, and has a visible double-layer capsid structure. Duck reovirus is sensitive to ultraviolet light, temperature and pH, but not to organic solvents. [0003] Du...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K39/15A61K39/12A61K39/235A61P31/14A61P31/20A61K39/39A61P37/04
CPCA61K39/12A61P31/14A61P31/20A61K39/39A61P37/04C12N2720/12234C12N2770/24134C12N2710/10234A61K2039/5252A61K2039/70A61K2039/55516A61K2039/55511
Inventor 张毓金严悌昆谢秉超黄淑芬张桂平
Owner 广州渔跃生物技术有限公司